Non-Clinical Topics

Despite Unanimous House Support, VA Opposes ‘Blue Water’ Legislation

by Sandra Basu

September 9, 2018
The USS Juneau, an Austin class amphibious transport dock, was one of the Navy vessels operating off the coast of Vietnam, beginning in August 1970. (Photo from Wikipedia)

WASHINGTON—VA officials told lawmakers last month that it opposes a bill that would expand the presumption of Agent Orange exposure to Vietnam veterans who served offshore because the “science is not there.”

Currently, VA only recognizes veterans who actually set foot in Vietnam or those who served in Vietnam’s inland waterways, known as “Brown Water” veterans, as qualifying for the presumption of exposure to Agent Orange. With the exception of non-Hodgkin lymphoma, VA does not include so-called Blue Water veterans in the presumption for the list of Agent Orange related-conditions, maintaining there is not enough evidence to do so.

“The National Academy of Medicine reviewed all scientific evidence concluding that it was unable to state with certainty that Blue Water Navy personnel were or were not exposed to Agent Orange,” Veterans Benefits Administration Undersecretary for Benefits Paul Lawrence, PhD, said last month.

Lawrence made his comments at a Senate Committee on Veterans’ Affairs hearing on various legislation, including the Blue Water Navy Vietnam Veterans Act of 2018. The bill would extend the presumption of exposure to Agent Orange to veterans who served on open sea ships off the shore of Vietnam during the Vietnam War. Lawrence explained that, if the bill becomes law, it would open the door for other causes “without valid science to petition Congress for compensation.”

Lawrence said that VA continues to study the issue and that a new VA health study that includes Blue Water veterans is ongoing and initial results are due in 2019 with publication of results potentially in one to two years.

“Nearly 1,000 Blue Water Navy veterans are included in this study at the time,” he said.

Unanimous House Vote

The Senate hearing came after a unanimous vote in the House of Representatives to address Agent Orange benefits for so-called Blue Water Navy veterans. The House passed its version of the bill 382-0.

“This bill is critical to our nation’s Blue Water Navy veterans, as it ensures they receive benefits for any condition they may have developed as a result of exposure to Agent Orange,” said House Committee on Veterans’ Affairs Chairman Rep. Phil Roe, MD, (R-TN) after the vote.

Veterans organizations and several lawmakers have been pushing for Senate passage of the bill.

“We now call on the Senate to take similar action on the Blue Water Navy Vietnam Veterans Act so that it can be sent to the president and finally signed into law this year,” Garry Augustine, executive director of Disabled American Veterans, said in a statement after the House vote.

Augustine said that “approximately 90,000 Navy veterans who served off the shores of Vietnam were potentially exposed to Agent Orange and other herbicides, but they haven’t been given the same presumption of service connection for Agent Orange-related illnesses as their fellow veterans who served on the ground in Vietnam.”

American Legion National Veterans Affairs and Rehabilitation Division Director Chanin Nuntavong explained in a written statement for the Senate committee hearing that “Vietnam veterans who served on the open sea now have health problems commonly associated with herbicide exposure.”

“Just as those who served on land were afforded the presumption because it would have placed an impossible burden on them to prove exposure, Congress should understand the injustice of placing the same burden on those who served offshore,” Nuntavong said.

‘Without Fair Evaluation’

During the Senate committee hearing, Lawrence told lawmakers that any veteran, including Blue Water Navy veterans, can apply for a claim and that claims are evaluated on a case-by-case basis. Sen. Joe Manchin (D-WV) responded that the bill has support, however, because veterans do not feel they are being evaluated fairly. He pointed to what he said was strong support for the bill in the House and suggested the bill would be supported by his colleagues.

“We have all had constituents who have been rejected without fair evaluation,” Manchin said.

Both the House and Senate legislation extend the presumption of herbicide exposure for veterans who served on or near the Korean Demilitarized Zone between Sept. 1, 1967, and Aug. 31, 1971.

The legislation extends certain benefits to any child who was born with spina bifida, if at least one of the child’s parents served in Thailand between Jan. 9, 1962, and May 7, 1975, and at least one of the parents had been exposed to a herbicide agent during that period.

Last year, veterans’ groups expressed disappointment when Blue Water legislation failed to move forward. Efforts to extend the benefits had been stymied by the approximate $1 billion price tag, as lawmakers couldn’t agree on how to pay for it.

The bill picked up some momentum and was approved by the House Committee on Veterans’ Affairs in May. Chairman Phil Roe, MD, (R-TN) said at that time that a bipartisan fix in the new bill had been created and would entail raising some fees for VA’s home loan program. VA has said it opposes funding the legislation in that manner.


Comments are closed here.


Related Articles

VA: Blue Water Veterans Must Wait Until 2020 for Claims to Be Processed

Vietnam Vets on Ships Won Fight for Presumptive Agent Orange Status WASHINGTON—Blue Water Navy veterans who want to file disability claims related to Agent Orange exposure will have to wait until next year to have... View Article

Debate Continues on Esketamine Efficacy and Safety for Depression Treatment

VA Panel Puts Limits on Use of Drug PHILADELPHIA—Is esketamine a revolutionary treatment for depression or just another moderately effective adjunctive medication with some potentially serious risks? The VA’s Medical Advisory Panel leaned toward the... View Article


U.S. Medicine Recommends


More From news

News

Democrats Look at VA Role of Trump’s Mar-a-Lago Associates

WASHINGTON—Congress announced last month that it will be opening an investigation into alleged improper influence by three civilian consultants to President Donald Trump on administration of the VA. The three men—Ike Perlmutter, CEO of Marvel... View Article

News

Legislators Question Whether VA Can Efficiently Implement Mission Act

Six months after President Donald Trump signed the VA MISSION Act–a bill that will, among other things, streamline and expand veterans’ access to non-VA healthcare providers–many legislators are concerned whether VA has the ability to implement the extensive provisions in the bill without the painful speed bumps experienced with past legislation.

News

VA Overall Appointment Wait Times Shorter than the Private-Sector

Despite intense scrutiny of wait times for veterans seeking VA care over the last three years, a new study pointed out that delays in the private sector weren’t statistically less in 2014 and that, possibly because of the focus, wait times now are significantly shorter for the VA compared to private-sector healthcare facilities.

News

Report Questions Quality of Outsourced VA Benefit Examinations

A review of outsourcing by the Veterans Benefits Administration raised issues about the quality of contractor examinations and also questioned whether a proposed solution will work as intended.

News

Suicide Rates Jump Up for Younger Veterans in Recent Years

Rates of suicide among younger veterans (ages 18-34) “increased substantially in recent years,” climbing from 40.4 suicide deaths per 100,000 population in 2015 to 45 suicide deaths per 100,000 population in 2016, according to a new report.

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up